These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22956151)

  • 41. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
    Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
    Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
    Gereige RS; Barrios NJ
    P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.
    Medeiros D; Buchanan GR
    J Pediatr; 1998 Sep; 133(3):334-9. PubMed ID: 9738712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment outcome of immune thrombocytopenia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2012 Oct; 153(41):1613-21. PubMed ID: 23045311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of amifostine in treating patients with idiopathic thrombocytopenia purpura.
    Fan H; Zhu HL; Li SX; Lu XC; Zhai B; Guo B; Yao SQ; Liu Y
    Cell Biochem Biophys; 2011 Jan; 59(1):7-12. PubMed ID: 21104159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
    Kjaersgaard M; Edslev PW; Rosthøj S
    Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura.
    Sikorska A; Konopka L; Maślanka K
    Int J Lab Hematol; 2008 Feb; 30(1):58-64. PubMed ID: 18190469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial.
    Rostami N; Keshtkar-Jahromi M; Rahnavardi M; Keshtkar-Jahromi M; Esfahani FS
    Am J Hematol; 2008 May; 83(5):376-81. PubMed ID: 18183613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination therapy for a pregnant woman with severe refractory ITP.
    Orisaka M; Shukunami K; Orisaka S; Goto K; Yoshida Y; Kotsuji F
    Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):119-20. PubMed ID: 15989989
    [No Abstract]   [Full Text] [Related]  

  • 52. [Infection-induced transient increase in the platelet count, and a transient remission of thrombocytopenia with high-dose intravenous gammaglobulin therapy during intercurrent pneumonia in chronic idiopathic thrombocytopenic purpura].
    Katoh M; Ishikawa I; Umeda M; Tsukahara T
    Rinsho Ketsueki; 1994 Mar; 35(3):296-9. PubMed ID: 8158852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of idiopathic thrombocytopenic purpura in elderly patients.
    Andrès E; Daou S; Zimmer J; Federici L; Maloisel F
    Eur J Haematol; 2007 Feb; 78(2):175. PubMed ID: 17313565
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding.
    Grimaldi D; Canouï-Poitrine F; Croisille L; Lee K; Roudot-Thoraval F; Languille L; Khellaf M; Michel M; Godeau B; Bierling P
    Ann Hematol; 2014 Feb; 93(2):309-15. PubMed ID: 23912633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful implementation of a watchful waiting strategy for children with immune thrombocytopenia.
    Bekker E; Rosthøj S
    Dan Med Bull; 2011 Apr; 58(4):A4252. PubMed ID: 21466762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life.
    Lowe EJ; Buchanan GR
    J Pediatr; 2002 Aug; 141(2):253-8. PubMed ID: 12183723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of idiopathic thrombocytopenic purpura with danazol].
    Ruberto E; Espinola R
    Sangre (Barc); 1995 Aug; 40(4):307-10. PubMed ID: 7482120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia.
    Zaja F; Volpetti S; Chiozzotto M; Puglisi S; Isola M; Buttignol S; Fanin R
    Am J Hematol; 2012 Sep; 87(9):886-9. PubMed ID: 22718483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Splenectomy in immune thrombocytopenia and other hematological diseases].
    Lanzi S; Lancini GP; Piardi T; Biasca F; Ottaviani GM; Rossi G; Pizzoccaro C; Pouchè A
    G Chir; 1999; 20(11-12):479-86. PubMed ID: 10645065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.